01 1DISHMAN CARBOGEN AMCIS LIMITED
01 1CRENOLANIB BESYLATE
01 1India
NDC Package Code : 61876-0722
Start Marketing Date : 2014-12-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
27
PharmaCompass offers a list of Crenolanib Besylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Crenolanib Besylate manufacturer or Crenolanib Besylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Crenolanib Besylate manufacturer or Crenolanib Besylate supplier.
PharmaCompass also assists you with knowing the Crenolanib Besylate API Price utilized in the formulation of products. Crenolanib Besylate API Price is not always fixed or binding as the Crenolanib Besylate Price is obtained through a variety of data sources. The Crenolanib Besylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Crenolanib Besylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Crenolanib Besylate, including repackagers and relabelers. The FDA regulates Crenolanib Besylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Crenolanib Besylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Crenolanib Besylate supplier is an individual or a company that provides Crenolanib Besylate active pharmaceutical ingredient (API) or Crenolanib Besylate finished formulations upon request. The Crenolanib Besylate suppliers may include Crenolanib Besylate API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Crenolanib Besylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Crenolanib Besylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Crenolanib Besylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Crenolanib Besylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Crenolanib Besylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Crenolanib Besylate suppliers with NDC on PharmaCompass.
We have 1 companies offering Crenolanib Besylate
Get in contact with the supplier of your choice:
